Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples